The opinion in support of the decision being entered today was not written
for publication and is not binding precedent of the Board.
UNITED STATES PATENT AND TRADEMARK OFFICE
__________
BEFORE THE BOARD OF PATENT APPEALS
AND INTERFERENCES
__________
Ex parte ISMAT ULLAH, and
NEMICHAND B. JAIN
__________
Appeal No. 2006-2471
Application No. 09/824,364
__________
ON BRIEF
__________
Before SCHEINER, GRIMES, and LEBOVITZ, Administrative Patent Judges.
LEBOVITZ, Administrative Patent Judge.
DECISION ON APPEAL
This appeal involves claims to methods of treating patients by administering a
pharmaceutical composition containing statin and aspirin. The examiner has rejected
the claims as obvious over prior art. We have jurisdiction under 35 U.S.C. § 134. We
affirm.
Background
Statins are a class of cholesterol lowering agents which are HMG CoA reductase
inhibitors. Specification, page 6, lines 6-7. Examples include atorvastatin (Lipitor®) and
prevastatin (Pravachol®). Id., page 7-11. “The use of aspirin for reducing the risk of a
myocardial infarction and the use of statins for lowering cholesterol and preventing or
Page: 1 2 3 4 5 6 7 8 9 10 11 12 Next
Last modified: November 3, 2007